Advertisement

Milzbrand

Part of the Infektionskrankheiten book series (INNEREN)

Zusammenfassung

Der Milzbrand oder Anthrax ist eine Infektionskrankheit der pflanzenfressenden Säugetiere, wie Rinder, Schweine usw., die meist als Septicämie verläuft. Der Mensch infiziert sich durch den Kontakt mit Produkten (Felle, Häute, Haare, Wolle usw.) von erkrankten Tieren oder, seltener, durch den direkten Kontakt mit kranken Tieren. In Europa verläuft die Erkrankung beim Menschen meist als Hautmilzbrand. Die früher öfter beobachtete Form des Lungenmilzbrandes ist sehr selten geworden. Der Darmmilzbrand wird noch in afrikanischen und anderen außereuropäischen Ländern häufiger beobachtet, in Deutschland und Mitteleuropa ist er praktisch verschwunden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Albrink, W.S., S.M. Brooks, R.E. Biron, and M. Kopel: Human inhalation anthrax. A report of three fatal cases. Amer. J. Path. 36, 457 (1960).PubMedGoogle Scholar
  2. Albrink, W.S., and R.J. Goodlow: Experimental inhalation anthrax in the chimpanzee. Amer. J. Path. 35, 1055 (1959).PubMedGoogle Scholar
  3. Aleksandrov, N.I., N.E. Gefen, A.P. Budak, I.V. Ezepchuk, A.I. Filippenko and V.F. Runova: Utilization of effective chemical vaccines against certain zoonoses. I. Production of chemical depot anthrax vaccine and determination of its effectiveness on animal experiments. Zh. Mikrobiol. (Mosk.) 32, 42 (1961). = Zh. Mikrobiol. Eng. 32, 830 (1961).Google Scholar
  4. Aleksandrov, N.I., N.E. Gefen, A.P. Budak, A.P. Runowa, J.W. Eseptschuk, and A.G. Bazhinow: A study of postvaccinal reactions in response to chemical sorbed anthrax vaccine on small groups of people. Zh. Mikrobiol. (Mosk.) 3, 32 (1963). = Zh. Mikrobiol. Eng. 40, 32 (1963).Google Scholar
  5. Aleksandrov, N.I., N.E. Gefen, K.G. Gapochko, and N.S. Garin: Aerosol-immunization with live vaccines and anatoxins. VI. Characteristics and dynamics of vaccinal processes after aerosolvaccination with brucellosis, tularemia, anthrax, and plague dust-vaccines. Zh. Mikrobiol. (Mosk.) 31, 38 (1960).Google Scholar
  6. Aleksandrov, N.I., N.E. Gefen, K.G. Gapochko, N.S. Garin, V.M. Sergeev, E.S. Lazareva, V.V. Mishchenko and E.N. Shliakhov: Aerosol immunization with dry live vaccines and anatoxins. VI. Studies on reactogenic and immunological effectiveness of the aerosol immunization with spray vaccines (brucellosis, tularemia, anthrax and plague) in man. Zh. Mikrobiol. (Mosk.) 32, 56 (1961).Google Scholar
  7. Aleksandrov, N.I., N.E. Gefen, N.S. Garin, K.G. Gapochko, V.M. Sergeev, M.S. Smirnov, A.L. Tamarin, and E.N. Shliakhov: Experience in massive aerogenic vaccination against anthrax. Vo.-med. Zh. No. 8, 27 (1959).Google Scholar
  8. Aleksandrov, N.I., N.E. Gefen, I. and S. Voronin et al.: Further experimental study of the efficacy of chemical anthrax vaccine. Zh. Microbiol. (Mosk.) 41, 45 (1964).Google Scholar
  9. Allende, C.J.: Anthrax de glándula parótica como complicación postoperatoria. Bol. Soc. Cirug. B. Aires 42, 332 (1958).Google Scholar
  10. Anders, W.: Epidemiologie des Milzbrandes 1958–1962 in der Bundesrepublik Deutschland. Bundesgesundheitsblatt 1964, 145.Google Scholar
  11. Armou de jr., J.A., F. Klein, R.E. Lincoln, B.G. Mahlandt, and A.L. Fernelius: Immunological studies of anthrax. I. An index to determinate quantitative immunization. J. Immunol. 87, 233 (1961).Google Scholar
  12. Baumhöfener, F.K.: Der Hautmilzbrand. Broschüre der Lederindustrie-Berufsgenossenschaft Mainz, 1966.Google Scholar
  13. Beall, F.A., and F.G. Dalldorf: The pathogenesis of the lethal effect of anthrax toxin in the rat. J. infect. Dis. 116, 377 (1966).PubMedGoogle Scholar
  14. Belloni, A.: Die Praecipitations- prüfung im Tropfen auf dem Objektträger, angewandt beim Thermo-Präzipitationsverfahren zur Diagnose des Milzbrandes. Dtsch. Schlacht- u. Viehhof-Ztg. 1957, 190.Google Scholar
  15. Berdjis, C.C., and C.A. Gleiser: Experimental subcutaneous anthrax in chimpanzees. Exp. Molec. Path. 3, 63 (1964).Google Scholar
  16. Berdjis, C.C., C.A. Gleiser, and H.A. Hartman: Experimental parenteral anthrax in Macaca mulatta. Brit. J. exp. Path. 44, 101 (1963).PubMedGoogle Scholar
  17. Berdjis, C.C., C.A. Gleiser, H.A. Hartman, R.W. Kuehne, and W.S. Gochenour: Pathogenesis of respiratory anthrax in Macaca mulatta. Brit. J. exp. Path. 43, 515 (1962).PubMedGoogle Scholar
  18. Biegeleisen, J. Z. jr., W.B. Cherry, P. Skaiy, and M.D. Moody: The demonstration of Bacillus anthracis in environmental specimens by conventional and fluorescent antibody techniques. Amer. J. Hyg. 75, 230 (1962).Google Scholar
  19. Billiottet, J. P. Desnues, et R. Crenes: Pustule maligne cervicale traitée par l’association Pénicilline-Streptomycine-Cortancyl; guérison par la Magnamycine d’une rechute immédiate localisée à la region présternale. Bull. Soc. méd. Hôp. Paris, 73, 930 (1957).PubMedGoogle Scholar
  20. Blagoweschtenskij, W. A., A. J. A. Kulberg, T. J. Bulatova, and M. J. A. Korn: Production of a specific fluorescent anthrax serum. Zh. Mikrobiol. (Mosk.) 33, 18 (1962).Google Scholar
  21. Bonventre, P.F., B.K. Nordberg, and C.G. Schmiterlow: An autoradiographic study of anthrax infection in the mouse. J. infect. Dis. 108, 205 (1961).Google Scholar
  22. Boudin, G., A. Lauras, et C. Vaillant: Etat de mal épileptique révélateur d’une méningite charbonneuse. Etude anatomo-clinique. Bull. Soc. méd. Hôp. Paris 115, 183 (1964).PubMedGoogle Scholar
  23. Bounhoure, R.L., Barrere, Guiraud, et M. Vinas: Les aspects médicaux et sociaux du charbon. Concours méd. 81, 2311 (1959).PubMedGoogle Scholar
  24. Brachman, P.S., and F.R. Fekety: Industrial anthrax. Ann. N.Y. Acad. Sei. 70, 574 (1958).Google Scholar
  25. Brachman, P.S., H. Gold, S.A. Plotkin, F.R. Fekety, M. Werrin, and N. R. Ingraham: Field evaluation of a human anthrax vaccine. Amer. J. publ. Hlth. 52, 632 (1962).Google Scholar
  26. Brachman, P.S., J.S. Pagano, and W.S. Albrink: Two cases of fatal inhalation anthrax, one associated with sarcoidosis. New Engl. J. Med. 265, 203 (1961).Google Scholar
  27. Brachman, P.S., S.A. Plotkin, F.H. Bumford, and M.M. Atchison: An epidemic of inhalation anthrax: the first in the twentieth century. ü. Epidemiology. Amer. J. Hyg. 72, 6 (1960).Google Scholar
  28. Brandis, H.: Über die Lebensdauer von Milzbrand- und Mesentericus- sporen. Zbl. Bakt., I. Abt. Orig., 177, 434 (1960).Google Scholar
  29. Büchlmann, E.: Der Einfluß des Klimas auf die Verbreitung gewisser Zoonosen. Wien, tierärztl. Mschr. 43, 904 (1962).Google Scholar
  30. Bundesgesundheitsamt: Ratschläge an Ärzte zur Bekämpfung des Milzbrandes beim Menschen. Merkbl. Nr. 6, Ausg. 1955.Google Scholar
  31. Canavosio, A.E., T. Recalde, et L. Serravalle: Consideraciones terapéuticas sobre carbunco. Rev. Fac. Cieñe, med. Univ. Córdoba 22, 49 (1964).Google Scholar
  32. Carr, E.A., and R.R. Rew: Detection of Bacillus anthracis from the nose and throat of apparently healthy workers. J. infect. Dis. 100, 169 (1957).PubMedGoogle Scholar
  33. Cominsky, N.C.: Histological changes in mice injected with Bacillus anthracis. Tex. Rep. Biol. Med. 17, 85 (1959).PubMedGoogle Scholar
  34. Cousineau, J.G., and R.J. McCleanaghan: Anthrax in bison in the Northwest Territories. Canad. Vet. J. 6, 22 (1965).Google Scholar
  35. Dahlgren, C.M., L. M. Buchanan, H.M. Decker, S.W. Freed, C.R. Phillips, and P.S. Brachman: Bacillus anthracis aerosols in goat hair processing mills. Amer. J. Hyg. 72, 24 (1960).PubMedGoogle Scholar
  36. D’Alessandro, G., and A. Gullotti: The “aggressive” property of carbuncle exudate studied in tissue culture in vitro. Riv. 1st. sieroter. ital. 37, 1 (1962).Google Scholar
  37. Deletraz, R., et J. Seranne: Un cas d’anthrax du rein guéri par le traitment médical. Marseille chir. 9, 686 (1957).Google Scholar
  38. Depaillat, A., J. Lacoste, and H. Lombard: Human anthrax and complex epizootic (cattle, swine, mink and dog). Bull. Acad. nat. Méd. (Paris) 144, 56 (1960).Google Scholar
  39. Deshpande, N.S.: Incidence of human anthrax in North Kanara. J. Indiana med. Ass. 32, 13 (1959).Google Scholar
  40. Dotta, J.S., and T. Delporte: Radiotherapy in the treatment of anthrax of the kidney. Rev. argent. Urol. 27, 332 (1958).PubMedGoogle Scholar
  41. Drawer, K.: Geographisch-statistische Auswertung der Milzbrand fälle bei Tieren im Kartogramm der Bundesrepublik Deutschland von 1954–1963. Tierärztl. Umsch. 20, 532 (1965).Google Scholar
  42. Ebert, B., L. Iüig u. K.F. Petersen: Zur Diagnose und Therapie des Milzbrandes der Haut. Med. Klin. (Munich) 57, 746 (1952).Google Scholar
  43. Ercole, R., and E. Mattos: Medical therapy of anthrax of the kidney (apropos of 5 personal cases). Rev. argent. Urol. 27, 269 (1958).PubMedGoogle Scholar
  44. Fanjul, R.: Ocular anthrax (= Carbunclo ocular). Arch. Oftal. B. Aires 38, 351 (1963).Google Scholar
  45. Felsenfeld, O.: The Epidemiology of Tropical Diseases. Springfield/Ill.: Charles & Thomas 1966.Google Scholar
  46. Franche, M., G. Teodorovici, C. Oana, J. Micu, D. Petrea, A. Ovalescu, O. Minecau, J. Josephsohn, T. Hurmuzache, G. Cuciureanu, et S. Popescu: Consideratü privid consumul de carne infectata eu Bac. anthracis. Rev. med. Cirug. Iasi 45, 379 (1961).Google Scholar
  47. Franěk, J.: Application of fluorescent antibodies for demonstrating B. anthracis in the organs of infected animals. J. Hyg. Epidem. (Praha) 8, 111 (1964).Google Scholar
  48. ~ Use of fluorescent antibodies for the rapid diagnosis of infections caused by B. anthracis and P. tularensis. J. Hyg. Epidem. (Praha) 9, 160 (1965).Google Scholar
  49. Gavrilă, J. u. M. Soloviev, M.: Epidemiologische und klinische Bemerkungen zum Milzbrand in Cluj (Rumänien) in den letzten 13 Jahren (1950–1962) Microbiologia (Buc.) 8, 445 (1963).Google Scholar
  50. Gentilini, M., V. Laroche, et A. Degremont: Aspects de la pathologie tropicale parasitaire et infectieuse en République d’Haiti. Bull. Soc. Path. exot. 75, 565 (1964).Google Scholar
  51. Ghossain, A.: Grave mesenteric adenitis and intestinal anthrax. Mém. Acad. Chir. 87, 289 (1961.PubMedGoogle Scholar
  52. Ghossain, A., and J. Hatem: Intestinal anthrax. Presse méd. 71, 1059 (1963).PubMedGoogle Scholar
  53. Gilissen, G., u. H.G. Scholz: Untersuchungen zur Abtötung von Milzbrandbazillen und deren Sporen. Desinfekt. Gesundheitsw. 52, 140 (1960).Google Scholar
  54. ~ Zur Sanierung milzbrandverseuchter Felle und Häute. Desinfekt. Gesundheitsw. 53, 33 (1961).Google Scholar
  55. ~ Zur Abtötung von Milzbrandsporen in Abwässern der Felle und Häute verarbeitenden Industrie. Gesundh.-Ing. 82, 372 (1961).Google Scholar
  56. Gleiser, C.A., C.C. Berdjis, H.A. Hartman, and W.S. Gochenour: Pathology of Experimental Respiratory Anthrax in Macaca Mulatta. Brit. J. exp. Path. 44, 416 (1963).PubMedGoogle Scholar
  57. Gochenour, W.S. jr., C.A. Gleiser, and W.D. Tigertt: Observations on Penicillin prophylaxis of experimental inhalation anthrax in the monkey. J. Hyg. (Lond.) 60, 29 (1962).Google Scholar
  58. Gochenour, W.S. jr., W.D. Sawyer, J.E. Henderson, C.A. Gleiser, R.W. Kuehne, and W.D. Tigertt: On the recognition and therapy of Simian woolsorter’s disease. J. Hyg. (Lond.) 61, 317 (1963).Google Scholar
  59. Gray, J.: Lysine deficiency and host resistance to anthrax. J. exp. Med. 117, 497 (1963).PubMedGoogle Scholar
  60. ~ Effect of protein nutrition on leucocyte mobilization. Proc. Soc. Exp. Biol. Med. 116, 414 (1964).PubMedGoogle Scholar
  61. Greenough, P. R.: Anthrax and antibiotics. Vet. Ree. 77, 784 (1965).Google Scholar
  62. Grishko, N.P.: Some peculiarities of the clinical manifestations and course of the cutaneous form of malignant anthrax in the Samarkandsk region. Med. Zh. Uzbek. 11, 46 (1962).PubMedGoogle Scholar
  63. Grumbach, A.: Die Infektionskrankheiten des Menschen und ihre Erreger. In: Grumbach u. Kikuth ü, S. 943, Stuttgart 1958.Google Scholar
  64. Gubina, E.A., and M.J. Chernysheva: Study of immunogenesis following vaccination with live associated vaccine. I. Study of immunogenesis in guinea pigs, vaccinated with Brucella and anthrax vaccine. Zh. Mikrobiol. (Mosk.) 41, 3 (1964).Google Scholar
  65. Gustafson, B.A., and S.E. Svehag: The resistance condition in Bac. anthracis and some anthrax-like organisms. Nord. Vet.-Med. 8, 902 (1956).Google Scholar
  66. Hanson, R.P.: The earliest account of anthrax in man and animals in North America. J. Amer. vet. med. Ass. 135, 463 (1959).PubMedGoogle Scholar
  67. Hepding, L., and H. Wahlig: Experimental studies on a new sulfonamide-penicillin combination. Arzneimittel-Forsch. 13, 41 (1963).Google Scholar
  68. Hill, W.K.W.: Die Diagnose „Milzbrand“. Diergeneesk. 85, 1797 (1960).Google Scholar
  69. Hoeden, J. van der: Zoonosen. Elsevier Publishing Comp., Amsterdam-London-New York 1964.Google Scholar
  70. Hörne u. Mitarb.: Inactivation of spores of Bac. anthracis by gamma-radiation. Nature (Lond.) 183, 475 (1959).Google Scholar
  71. Isopescu, J., G. Grasoiu, M. Stanca, u. A. Danescu: Beobachtungen über die Dauer der Immunität bei Milzbrand. Lucr. Stünt. Inst. ser. Vaccin. Pasteur, Bucuresti 4, 147 (1960).Google Scholar
  72. Isopescu, J., G. Grasoiu u. O. Burducea: Die Resistenz von Bac. anthracis (Stamm 1190) im Organismus der Meerschweinchen. Lucrarile Stünt. Inst, seruri Vaccinuri Pasteur, Bucuresti 5, 249 (1961).Google Scholar
  73. Jackson, F.C., G.G. Wright, and J. Armstrong: Immunisation of cattle against experimental anthrax with alum-precipitated protective antigen or spore vaccine. Am. J. Vet. Res. 18, 771 (1957).PubMedGoogle Scholar
  74. Jacotot, H., et B. Virat: Vaccination contre l’infection charbonneuse par injection de bactéridies tuées en excipient huileux. 1. Note: Ann. Inst. Pasteur 98, 297 (1960). 2. Note: Ann. Inst. Pasteur 104, 822 (1963).Google Scholar
  75. Johnson, W.P., and R.C. Percival: Tetracycline therapy of experimentally induced anthrax in sheep. J. Amer. vet. med. Ass. 127, 142 (1955).PubMedGoogle Scholar
  76. Jordan, W.J.: An outbreak of acute disease in Chester Zoo diagnosed as anthrax. Vet. Ree. 76, 927 (1964).Google Scholar
  77. Kaleque, K.A., M.G. Muazzam, and R.J. Chowdhury: Anthrax in East Pakistan. J. trop. Med. Hyg. 64, 18 (1961).Google Scholar
  78. Kasian, A. J.: Some data on the therapeutic properties of D-17 mycetin. Farm. Zh. 19, 42 (1964).PubMedGoogle Scholar
  79. Karsemeyer, M.: Milzbrand-Erfahrungen in Praxis und Fleischbeschau. Diergeneesk. 85, 1780 (1960).Google Scholar
  80. Kaukker, E.: Globale Verbreitung des Milzbrandes um 1960. Sitzungsber. d. Heidelberger Akad. d. Wissensch., 2. Abhdl., Berlin-Heidelberg-New York: Springer 1965.Google Scholar
  81. Kaukker, E., u. K. Zettl: Milzbrand in der Welt (1955 bis 1961). Berl. Münch, tierärztl. Wschr. 76, 172 u. 194 (1963).Google Scholar
  82. Khan, A.M., and N. Ahmad: Outbreak of cutaneous anthrax in Jhang district, West Pakistan, in 1962. Pak. J. Hlth. 12, 76 (1962).Google Scholar
  83. Klein, F. et al.: Pathophysiology of anthrax. J. infect. Dis. 116, 123 (1966).PubMedGoogle Scholar
  84. Klein, F., J. A. de Armon jr., R.E. Lincoln, B.G. Mahlandt, and A.L. Fernelius: Immunological studies of anthrax. ü. Levels of immunity against Bac. anthracis obtained with protective antigen and live vaccine. J. Immunol. 88, 15 (1962).PubMedGoogle Scholar
  85. Klein, F., B.W. Haines, B.G. Mahlandt, J. A. de Armon jr., and R.E. Lincoln: Immunologic studies of anthrax. üI. Comparison of antibody titer and immunity index after anthrax immunization. J. Immunol. 91, 431 (1963).PubMedGoogle Scholar
  86. ~ Dual nature of resistance mechanisms as revealed by studies of anthrax septicaemia. J. Bact. 85, 1032 (1963).PubMedGoogle Scholar
  87. Klein, F., D.R. Hodges, B.G. Mahlandt, W.J. Jones, B.W. Haines, and R.E. Lincoln: Anthrax toxin: causative agent in the death of rhesus monkeys. Science 138, 1331 (1962).PubMedGoogle Scholar
  88. Klein, F., B.G. Mahlandt, R.E. Lincoln, J.A. de Armon jr., and A.L. Fernelius: Immunization as a factor affecting the course of septicemic anthrax. Science 133, 1021 (1961).PubMedGoogle Scholar
  89. Klemm, D.M., and W.R. Klemm: A history of anthrax. J. Amer. vet. med. Ass. 135, 458 (1959).PubMedGoogle Scholar
  90. Kneidel, H.: Die heutige Bedeutung des Milzbrandes als Berufskrankheit. Dtsch. Gesundh.-Wes. 16, 103 (1961).Google Scholar
  91. Koelbing, H.: persönliche Mitteilung.Google Scholar
  92. König, A.: Milzbrand-Epizootie in einer Schafherde. Dtsch. tierärztl. Wschr. 63,473 (1956).Google Scholar
  93. Kohout, E., A. Sehat, and M. Ashraf: Anthrax, a continuous problem in Southwest Iran. Amer. J. med. Sei. 247, 565 (1964).Google Scholar
  94. Korczak, M.: Milzbrand in der Wojewodschaft Krakau in den Jahren 1945–1960. Med. weteryn. 18, 294 (1962).Google Scholar
  95. Lagrange, E.: L’action antibiotique des sucres sur le B. anthracis. Compt. Rend. Soc. Biol. 150, 1042 (1956).Google Scholar
  96. Lausecker, H.: Zur Erkennung und Behandlung des Milzbrandes. Wien. klin. Wschr. 68, 917 (1956).PubMedGoogle Scholar
  97. Lebedev, V.N.: On the problem of recovery in anthrax lesions in the intestine. Sovetsk. Med. 25, 134 (1961).Google Scholar
  98. Leiman, V.N.: Epidemiological and clinical data on anthrax. Zh. Mikrobiol. (Mosk.) 30, 130 (1959).Google Scholar
  99. Londrillo, A.: Research on the action of Erythromycin on guinea pigs inoculated with Bac. anthracis. Boll. Soc. ital. Biol. sper. 36, 59 (1960).PubMedGoogle Scholar
  100. Lutynski, R.: Milzbrand beim Menschen in der Wojewodschaft Krakau. Med. weteryn. 19, 576 (1963).Google Scholar
  101. Lutz, R. (Bawku Hospital, Ghana): Mündl. Mitteilung.Google Scholar
  102. Ma, Hai-Teh, and Ho, Ta-Hsun: Treatment of cutaneous anthrax with Penicillin and Sulfadiazine. China Med. J. 75, 316 (1957).Google Scholar
  103. Makarov, N.J.: Anthrax morbidity among the inhabitants of the Precaucasian and Transcaucasian Republics and its control. Zh. Mikrobiol. (Mosk.) 33, 105 (1962).Google Scholar
  104. Mâlek, P. J. Kolc, u. F. Zäk: Die experimentelle Anthrax-Infektion im Lymphographischen Bild. Zbl. Bakt., I. Abt. Orig., 174, 94 (1959).Google Scholar
  105. Manelis, G.: Anthrax in Israel. Harefuah 54, 230 (1958).PubMedGoogle Scholar
  106. Marchette, N.J., D.L. Lundgren, and K. L. Smart: Intracutaneous anthrax infection in wild rodents. J. infect. Dis. 101, 148 (1957).PubMedGoogle Scholar
  107. Mardarowicz, C., B. Szyszko, and R. Malec: Some epidemiologic observations on cases of anthrax treated at the Clinic of Infectious Diseases of the Lublin Medical Academy. Wiad. lek. 18, 565 (1965).PubMedGoogle Scholar
  108. Marinesco, G.: Sur une forme peu connue du charbon cutané: la forme bulleuse ou pluribulleuse. Presse méd. 72, 2209 (1964).PubMedGoogle Scholar
  109. Maschke, R.: Milzbrand beim Kind. Dtsch. Gesundh.-Wes. 15, 2416 (1960).Google Scholar
  110. Mathois, H.: Zur Anwendung der Agardoppeldiffusion in der Milzbrand-Diagnostik. Mh. Tierheilk. 14, 407 (1962).Google Scholar
  111. Matz, M.H., and H.G. Brugsch: Anthrax in Massachusetts: 1943–1962. J. A. M. A. 188, 635 (1964).PubMedGoogle Scholar
  112. Mazaré, Y.: Le traitment du charbon (pustule maligne). Sem. Hôp. Paris 34, 356 (1958).PubMedGoogle Scholar
  113. McCulloch, B.: Pulmonary anthrax in cattle. Vet. Ree. 73, 805 (1961).Google Scholar
  114. McGann, V.G., R.L. Stearman, and G.G. Wright: Studies on immunity in anthrax. VüI. Relationship of complement-fixing activity to protective activity of culture filtrates. J. Immunol. 86, 458 (1961).Google Scholar
  115. Meloni, G. A., et J. D’Adda: Influenza del calcio sulla sporulazione del B. anthracis. L’lgiene moderna 50, 242 (1957).Google Scholar
  116. Micheletti, A., P. Navarranne, and B. Renault: Apropos of a case of anthrax of the kidney cured medically. J. Méd. Bordeaux 136, 1038 (1959).PubMedGoogle Scholar
  117. Middleton, G.K., and A.C. Standen: The electrocardiogram in fatal anthrax bacteremia. J. Infect. Dis. 108, 85 (1961).PubMedGoogle Scholar
  118. Mikhailov, M.: Case of gastric anthrax. Khirurgiya, (Sofiya) 11,659 (1958).Google Scholar
  119. Miller, J.K.: Human anthrax in New York State. N. Y. med. J. 61, 2046 (1961).Google Scholar
  120. Mindera (Pater), Kloster Benediktbeuren: Mündl. Mitteilung.Google Scholar
  121. Möckel, A.: Impfmilzbrand bei Ziegen. Mh. Vet.-Med. 18, 624 (1963).Google Scholar
  122. Mohr, W.: Milzbrand. In: Handb. d. inn. Med., 4 Aufl., Bd. I, Infektionskrankheiten. Berlin-Göttingen-Heidelberg: Springer 1952 (dort auch ältere Literaturangaben).Google Scholar
  123. ~ Die Therapie des Milzbrandes mit Penicillin und Aureomycin. Dtsch. Arch. klin. Med. 201, 57 (1954).PubMedGoogle Scholar
  124. ~ Milzbrand. In: Klinik der Gegenwart, Bd. IV, S. 9. München: Urban u. Schwarzenberg 1956.Google Scholar
  125. ~ Der Milzbrand in Deutschland. Landarzt 36, 9 (1960).Google Scholar
  126. ~ Le Charbon en Allemagne. In: L’Evolution Médicale, Bd. IV, No. 2, S. 185 (1960).Google Scholar
  127. ~ Milzbrand. In: Handb. d. Kinderhk., Bd. V, S. 605. Berlin-Göttingen-Heidelberg: Springer 1963.Google Scholar
  128. Mohr, W., u. H. Lippelt: Verfahren für das Vorgehen bei der Untersuchung einer Hautefflorescens auf Milzbrandbazillen. Rundschreiben an alle für Milzbranderkrankte zugelassene Krankenhäuser. Lederindustrieberufsgenossenschaft (1957).Google Scholar
  129. Moya, V., and A. Valdivieso: Current status of anthrax in the Americas. Bol. Ofic. sanit. panamer. 55, 84 (1963).PubMedGoogle Scholar
  130. Ness, G.B. van, S.A. Plotkin, R.H. Huffaker, and W.G. Evans: The Oklahoma-Kansas anthrax epizootic of 1957. J. Amer. vet. med. Ass. 134, 125 (1959).Google Scholar
  131. Nestor, L.: Über eine durch spezifische Bakteriophagen erhaltene Mutante des Anthraxbazillus mit den Merkmalen eines Coccus. Arch. roum. Path. exp. 25, 383 (1966).Google Scholar
  132. Nhonoli, A.M.: Cutaneous anthrax in Moshi district. E. Afr. med. J. 37, 37 (1960).Google Scholar
  133. Nusshag, W., u. R. v. d. Aa: Ein Beitrag zur Geschichte des Milzbrandes. Mh. Vet.-Med. Leipzig 1956, 248.Google Scholar
  134. Oganezov, A. V.: Clinic-epidemiological characteristics and treatment of anthrax according to data of the Kirovabad City Infectious Disease Hospital. Azerbaïdzh. med. Zh. 11, 56 (1963).Google Scholar
  135. Pienaar, U. de v.: Ein zweiter Ausbruch von Milzbrand beim Wild im Krüger-Nationalpark (5. 6.—11. 10. 1960). Koedoe Nr. 4, 4 (1961).Google Scholar
  136. Piening, C.: Gehäuftes Auftreten von Milzbrand im Lande Schleswig-Holstein bei Rindern. Berl. Münch, tierärztl. Wschr. 71, 474 (1958).Google Scholar
  137. Plotkin, S.A., P.S. Brachman, M. Utell, F.H. Bumford, and M.M. Atchison: An epidemic of inhalation anthrax, the first in the twentieth century. I. Clinical features. Amer. J. Med. 29, 992 (1960).PubMedGoogle Scholar
  138. Poljak, V.: Fälle von Anthrax des Menschen in der Ostslowakei. Vet. Cas. 3, 258 (1957).Google Scholar
  139. Ponomareva, T.N.: On the problem of the bacteriological diagnosis of anthrax. Zh. Mikrobiol. (Mosk.) 40, 107 (1963).Google Scholar
  140. Punskü, E.E., and D.V. Zheglova: Role of camels in epidemiology of anthrax. Zh. Mikrobiol. (Mosk.) 29, 78 (1958).Google Scholar
  141. Puziss, M., and G.G. Wright: Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man. J. Bact. 85, 230 (1963).PubMedGoogle Scholar
  142. Puziss, M., and M.B. Howard: Studies on immunity in anthrax. XI. Control of cellular permeability by bicarbonate Jon in relation to protective antigen elaboration. J. Bact. 85, 237 (1963).PubMedGoogle Scholar
  143. Rashkov, K., T. Shirikorad, and E. Neftianova: Anthrax in the Tirnovo District in 1958 bis 1962. Suvr. Med. 15, 16 (1964).Google Scholar
  144. Rubtsov, J.V.: On the history of the study of anthrax in Russia. Path, et Biol. 12, 152 (1964).Google Scholar
  145. Ruiz Sánchez, F., and A. Ruiz Sánchez: Kanamycin in anthrax, typhoid, paratyphoid, and brucellosis. Ann. N. Y. Acad. Sei. 76, 235 (1958).Google Scholar
  146. Ruiz Sánchez, F., A. Ruiz Sánchez, and E. Naranjo Granda: Treatment of human and experimental Anthrax with Tetracycline. Antibiot. Med. 3, 250 (1956).Google Scholar
  147. Rutquist, L., u. O. Swahn: Epizootologische und bakteriologische Untersuchungen über die Milzbrand-Epizootie in Schweden 1956–1957. Nord. Vet.-Med. 9, 641 (1957).Google Scholar
  148. Samokhvalov, V.G.: Multiple skin ulcers in anthrax. Sovetsk. Med. 23, 141 (1959).Google Scholar
  149. Sasso, B.: Malignant pustule of the eyelids and its consequences. Ann. Oculist. (Paris) 194, 54 (1961).Google Scholar
  150. Seidel, G.: Die aeroben Sporenbildner unter besonderer Berücksichtigung des Milzbrandbazillus. In: Beiträge zur Hygiene und Epidemiologie, H. 17. Leipzig, Barth 1963.Google Scholar
  151. ~ Über Probleme der Bekämpfung des Milzbrandes und der Differentialdiagnose des Bac. anthracis. Zbl. ges. Hyg. 9, 688 (1963).Google Scholar
  152. Semple, A.B., and T.L. Hobday: Control of anthrax. Suggestions based on survey of imported hides. Lancet 1959 ü, 507.Google Scholar
  153. Senchuk, T.T.: On the epidemiology of anthrax in Belorussia/SSR. Zdravookhr. Beloruss. 9, 57 (1963).Google Scholar
  154. Shliakhov, E.N.: Distribution, epidemiological characteristics and control of anthrax in foreign countries. Zh. Mikrobiol. (Mosk.) 28, 137 (1957).Google Scholar
  155. Silantiev, E. J., V.A. Ankudinov, and S.G. Kolesov: Anthrax immunity in the action of ionizing radiation on the organism. Zh. Mikrobiol. (Mosk.) 33, 121 (1962).Google Scholar
  156. Simmonds, N.T.: Anthrax of the eyelid. Amer. J. Ophthal. 49, 838 (1960).PubMedGoogle Scholar
  157. Skliarov, V.J.: On the spread of anthrax in the Stavropol region. Path, et Biol. 12, 138 (1964).Google Scholar
  158. Skvortsova, E.K., and N.P. Likhacheva: Electron microscope study of morphological changes in intestinal bacteria and anthracoids following administration of some phenol preparations. Zh. Mikrobiol. (Mosk.) 40, 88 (1963).Google Scholar
  159. Slein, M. W., and G.F. Logan jr.: Mechanism of action of the toxin of Bac. anthracis. I. Effect in vivo on some blood serum components. J. Bact. 80, 77 (1960). ü. Alkaline phosphatasemia produced by culture filtrates of various bacilli. J. Bact. 83, 359 (1962).PubMedGoogle Scholar
  160. Smith, H.: The basis of immunity to anthrax. Proc. roy. Soc. Med. 51, 375 (1958).PubMedGoogle Scholar
  161. Smith, H., and J. Keppie: The terminal phase of anthrax. Brit. J. exp. Path. 43, 684 (1962).PubMedGoogle Scholar
  162. Smith, H., and J.L. Stanley: Purification of the third factor of anthrax toxin. J. gen. Microbiol. 29, 517 (1962).PubMedGoogle Scholar
  163. Sokol, A.: Über die Verwendbarkeit lebender Milzbrand-Adsorbatvakzine bei Schafen. Vet. Cas. 4, 305 (1957).Google Scholar
  164. Standfuß, R.: Der Milzbrand der Tiere im Hinblick auf den Milzbrand als Berufskrankheit des Menschen. Münch, med. Wschr. 100, 858 (1958).Google Scholar
  165. Stanley, J.L., K. Sargeant, and H. Smith: Purification of factors 1 and 2 of the anthrax toxin in vivo. J. gen. Microbiol. 22, 206 (1960).PubMedGoogle Scholar
  166. Stanley, J. L., and H. Smith: Purification of factor one and recognition of a third factor of the anthrax toxin. J. gen. Microbiol. 26, 49 (1961).PubMedGoogle Scholar
  167. Steffen, J.: Milzbrand bei Nerzen. Vet. Bull. (Weybridge) 31,434 (1961).Google Scholar
  168. Steudte, E.: Beitrag zum Problem des primären Darmmilzbrand. Zahnärztl. Fortbild. (Jena) 57, 286 (1963).Google Scholar
  169. Tasselli, E.: Hematic carbuncle in the province of Foggia. Sanit. Pubbl. 23, 33 (1962).Google Scholar
  170. Taylor, M. J., G.H. Kennedy, and G.P. Bundell: Experimental anthrax in the rat. I. The rapid increase of natural resistance observed in young hosts. Amer. J. Path. 38, 469 (1961).PubMedGoogle Scholar
  171. Taylor, M. J., J.R. Rooney, and G.P. Bundell: Experimental anthrax in the rat. ü. The relative lack of natural resistance in germ-free hosts. Amer. J. Path. 38, 625 (1961).PubMedGoogle Scholar
  172. Théodoridès, J.: Casimir Davaine et les Débuts de la Bactériologie Médicale. Conférence donnée au Palais de la Découverte (Université de Paris), 1963. Alençon (Orne) Imprimerie Alençonnaise 1964. Die französische Bakteriologie im 19. Jahrhundert. Documenta Geigy „Infektion und Asepsis“. Basel: J.R. Geigy AG 1965.Google Scholar
  173. Thorne, C.B., D.M. Molnar, and R.E. Strange: Production of toxin in vitro by bacillus anthracis and its separation into two components. J. Bact. 79, 450 (1960).PubMedGoogle Scholar
  174. Timofeew, M.K., W.J. Karelina, and J. P. Koyschew: An outbreak of anthrax on the Arzamas-Gorkü cattle trail. Zh. Microbiol. (Mosk.) 33, 32 (1962).Google Scholar
  175. Todorovic, K.: Milzbrand in Jugoslawien.Google Scholar
  176. Mündl. Mitteilung.Google Scholar
  177. Vega-Núñez, J.: Pustula maligna. Estudio de 23 casos en la ciudad de Morelia. Dermatología, (Méx.) 4, 4 (1960).Google Scholar
  178. Vita, A., A. Secu, G. Cuciureanu, M. Leibovici, C. Bejenariu, and G. Cutu: Considerations on 3 cases of meningo-encephalitis due to anthrax bacilli. Rum. med. Rev. 5, 36 (1961).PubMedGoogle Scholar
  179. Völker, H.: Beitrag zur Ermittlung eines Milzbrandfalles durch die bakteriologische Fleischuntersuchung. Mh. Vet.-Med. 15, 887 (1960).Google Scholar
  180. Voronin, J.S., S.A. Dzharylgasov, J. S. Pisarevskü et. al.: The golden (Syrian) hamster as an experimental model in anthrax. Zh. Mikrobiol. (Mosk.) 40, 120 (1963).Google Scholar
  181. Witzmann, Chr. (Legau/Allgäu): Mündl. Mitteilung.Google Scholar
  182. Yoshida, J., K. Sugimura, and M. Hayashi: Killing effect of 60 Co-gamma rays and acquired resistance of Bac. anthracis by successive irradiation. Nat. Inst. Animal. Health. Quart. 2, 207 (1962).Google Scholar
  183. Zander, G.: Zur Differentialdiagnose des Furunkels. Dtsch. med. Wschr. 1952, 331.Google Scholar
  184. Zaporozhchenko, A. J.: Epidemiology and clinical aspects of the intestinal form of anthrax. Zh. Mikrobiol. (Mosk.) 32, 41 (1961).Google Scholar
  185. ~ The epidemiology and clinical course of intestinal anthrax. Zh. Mikrobiol. (Eng.) 32, 1226 (1962).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1968

Authors and Affiliations

  • W. Mohr
    • 1
  1. 1.HamburgDeutschland

Personalised recommendations